YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2025Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study ANNALS OF ONCOLOGY
2025Subcutaneous versus intravenous amivantamab, both in combination with lazertinib, in refractory EGFR-mutated non-small cell lung cancer: Patient satisfaction and resource utilization results from the PALOMA-3 study EUROPEAN JOURNAL OF CANCER
2025Trends in serum phosphate, calcium, and parathyroid hormone levels according to renal function following denosumabOSTEOPOROSIS INTERNATIONAL
2025Evolving roles of MET as a therapeutic target in NSCLC and beyondNATURE REVIEWS CLINICAL ONCOLOGY
2025Clinical Characteristics and Management of Statin-Associated Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy JOURNAL OF CLINICAL MEDICINE
2025An Artificial Intelligence-Enabled Electrocardiogram to Evaluate Patients With Dyspnea in the Emergency Department MAYO CLINIC PROCEEDINGS-INNOVATIONS QUALITY & OUTCOMES
2025BP and Kidney Disease Progression in Advanced CKD Findings from the Chronic Renal Insufficiency Cohort and KoreaN Cohort Study for Outcome in Patients with CKD StudiesCLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
2025Epidemiology of osteoporotic ankle fractures in South Korea: a nationwide retrospective cohort study (2006-2022)OSTEOPOROSIS INTERNATIONAL
2025FGFR2b protein overexpression: An emerging biomarker in gastric and gastroesophageal junction adenocarcinoma CANCER TREATMENT REVIEWS
2025Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohort CANCER
2025Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study JOURNAL OF CLINICAL ONCOLOGY
2025Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 studyLANCET ONCOLOGY
2025Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (−) metastatic breast cancer patients in Korea (KCSG BR21-15) BREAST
2025Therapeutic potential of sulfasalazine for sarcopenia: Insights from mouse models and clinical data EXPERIMENTAL GERONTOLOGY
2025Comparison of High-Dose versus Low-Dose Paclitaxel Drug-Coated Balloons for Native Femoropopliteal Artery Disease: An Analysis of the K-VIS ELLA Registry YONSEI MEDICAL JOURNAL
2025Procedural and clinical risk factors of infective endocarditis – A nationwide case-control study in South Korea JOURNAL OF INFECTION AND PUBLIC HEALTH
2025Meeting Physical Activity Guidelines: Impact on Chronic Kidney Disease Prevalence in Diabetic Individuals YONSEI MEDICAL JOURNAL
2025Pericoronary Adipose Tissue Attenuation in Patients with Future Acute Coronary Syndromes: The ICONIC StudyRADIOLOGY-CARDIOTHORACIC IMAGING
2025Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies PULMONARY CIRCULATION(Pulmonary circulation)
2025Intravascular Ultrasound Predictors of 12-Month Patency Loss Following Drug-Coated Balloon Angioplasty for the Femoropopliteal ArteryAMERICAN JOURNAL OF CARDIOLOGY
1234567891011 756

Recent Submissions

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links